Welcome to our dedicated page for Gbt Technologies news (Ticker: GTCH), a resource for investors and traders seeking the latest updates and insights on Gbt Technologies stock.
News and press releases about GBT Technologies Inc. (GTCH) highlight its activities as a development stage company focused on Internet of Things (IoT), Artificial Intelligence (AI), and integrated circuit (IC) technologies, along with evolving strategic initiatives. Readers of this news feed can follow how the company communicates progress on technology development, intellectual property, corporate strategy, and leadership changes.
Coverage includes updates on AI-driven electronic design automation (EDA) and semiconductor-related patents developed through its 50% subsidiary GBT Tokenize Corp, such as microchip reliability verification and auto-correction technologies, automatic IC layout generation, predictive 3D multi-planar semiconductor design, and photonic integrated circuit architectures. These announcements provide insight into the company’s IP portfolio and research focus.
GTCH news also addresses broader strategic moves, including its stated intention to transition toward a merchant banking platform under the Wertheim & Company name, subject to approvals, and non-binding agreements to acquire Nexus Workspace properties and related intellectual property through a planned subsidiary. Press releases describe the contemplated phased acquisition structure and potential spin-off of Nexus Workspace Holdings into an independent public entity, while emphasizing that such transactions remain subject to definitive agreements and customary conditions.
Recent items feature the formation of Cube Wellness Technologies, a wholly-owned subsidiary focused on AI-enabled wellness infrastructure deployed through smart automated systems and institutional partnerships, as well as leadership changes such as the appointment of an Interim Chief Executive Officer documented in a Form 8-K filing. This news page aggregates these company communications so investors and observers can review how GBT Technologies presents its technology ambitions, subsidiary activities, and corporate developments over time.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
GBT Technologies Inc. (GTCH) announced updates regarding its intellectual property (IP) portfolio, emphasizing its focus on research and development. The company now holds 14 patents and has submitted 25 new applications across various technology domains, including AI, cybersecurity, and healthcare. In Q1 2023, GBT achieved a 12.5% growth in its IP portfolio, adding four approved patents. The core AI technology, AVANT! AI™, has been trademarked and is available for licensing. Additionally, GBT signed a letter of intent with Bannix Acquisition Corp to license its Apollo technology for enhancing safety in autonomous vehicles. The company remains optimistic about future growth, highlighting established partnerships and advancing its IP portfolio.
GBT Technologies Inc. (OTC PINK: GTCH) announced the upcoming granting of U.S. patent number 11,638,523 for its AI-driven health monitoring device, qTerm, on May 2, 2023. This patent protects a sophisticated technology for measuring vital signs like body temperature, blood oxygen, and heart rate with a finger touch. The device, developed in 2022, includes mobile and web applications for data tracking and remote telemedicine capabilities. GBT aims to enhance qTerm with future releases featuring blood pressure monitoring and advanced AI analytics. A continuation patent will also be filed to strengthen its intellectual property. This development reflects GBT's commitment to creating innovative health tech solutions.